DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Murray JA, Kelly CP, Green PH. et al.
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Gastroenterology 2017;
152: 787-798 e2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.